InvestorsHub Logo

WebSlinger

05/28/21 12:11 PM

#223984 RE: arachnodude #223983

<< Where has this been reported? >>

In the two S-1s that were filed by the company with the SEC.

One of the S-1s (Registration #333-238883) will be diluting about $24 million worth of shares (or about 185 million shares at today's prices).

The other S-1 (Registration #333-255041) will be diluting over 200 million shares:

"Pursuant to this prospectus, the selling shareholders identified herein (each a “Selling Shareholder” and, collectively, the “Selling Shareholders”) are offering on a resale basis, up to 207,750,197 shares of common stock, no par value per share (the “common stock”) of Kraig Biocraft Laboratories, Inc. (the “Company,” “Kraig,” “we,” “our” or “us”)."